Characteristics of norepinephrine and clonidine displacement of [3H]yohimbine binding to platelet alpha2-adrenoreceptors in healthy volunteers.
Clonidine's estimates of platelet alpha2-adrenoreceptor (alpha2AR) density are substantially lower than yohimbine's. This discrepancy could have contributed to inconsistent results from studies on the role of alpha2AR in depression. Furthermore, few studies have investigated the relative distribution of alpha2AR between the high- and low-affinity states or their Gi protein coupling. [3H]yohimbine saturable binding to platelet alpha2AR, its displacement by norepinephrine and clonidine, and the effects of Gpp(NH)p on agonist displacement curves were investigated in 11 healthy volunteers. Clonidine estimates of alpha2AR density were close to norepinephrine estimates, and both were strongly correlated. Clonidine's K(L)/K(H) ratio was lower than norepinephrine's, consistent with its partial agonist nature. Norepinephrine and clonidine displacement curves revealed two affinity states. Gpp(NH)p induced a significant rightward shift to a single low-affinity state. When used in combination with a specific antagonist, clonidine's estimates of alpha2AR density were similar to those of norepinephrine's, and both were higher than previously reported, when clonidine was used alone. Re-evaluation of previous studies on alpha2AR in depression using clonidine is needed. The combined use of antagonist-saturation and agonist-displacement experiments to examine possible dysregulation in alpha2AR coupling to Gi protein in psychiatric disorders is recommended.
Gurguis
G N
GN
Department of Veterans Affairs Medical Center (116A), Dallas, TX 75216, USA. gurguis.george@dallas.va.gov
Vo
S P
SP
Blakeley
J
J
Orsulak
P J
PJ
Rush
A J
AJ
D000328:Adult; D001665:Binding Sites; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D003000:Clonidine / Q000494:pharmacology*; D003627:Data Interpretation, Statistical; D019204:GTP-Binding Proteins / Q000737:chemistry; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D009638:Norepinephrine / Q000494:pharmacology*; D018341:Receptors, Adrenergic, alpha-2 / Q000097:blood / Q000187:drug effects*; D015016:Yohimbine / Q000493:pharmacokinetics*
D018341:Receptors, Adrenergic, alpha-2; D015016:Yohimbine; D019204:GTP-Binding Proteins; D003000:Clonidine; D009638:Norepinephrine